SCHEMBL2017389

SCHEMBL2017389

COc1cccc(C(=O)NCCC(Cc2ccccc2)N(C)C(=O)c2c(C)nn3ccccc23)n1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.41
HCRTR2 O43614 2/20 0.41
CTSA P10619 1/20 0.37
KLKB1 P03952 1/20 0.36
KDM4E B2RXH2 4/20 0.35
HSD17B10 Q99714 1/20 0.35
POLB P06746 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRK1 P41145 1/20 0.34
HTR1A P08908 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
DRD3 P35462 1/20 0.33
TAS2R8 Q9NYW2 1/20 0.33
TP53 P04637 1/20 0.33
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2014386 0.90 HCRTR1 (0.42) HCRTR1HCRTR2CTSAKDM4EPOLB
SCHEMBL2012675 0.81 HCRTR1 (0.57) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2016502 0.81 HCRTR1 (0.49) HCRTR1HCRTR2CTSAKLKB1HSD17B10
SCHEMBL2013880 0.79 HCRTR1 (0.46) HCRTR1HCRTR2CTSAKLKB1KDM4E
SCHEMBL2011408 0.79 HCRTR1 (0.43) HCRTR1HCRTR2CTSAKLKB1KDM4E
SCHEMBL2011075 0.79 HCRTR1 (0.62) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2012216 0.78 EPHX2 (0.47) HCRTR1HCRTR2KLKB1HTR1AHTR2A
SCHEMBL2016060 0.78 HCRTR1 (0.43) HCRTR1HCRTR2CTSAKLKB1KDM4E
SCHEMBL2014058 0.77 HCRTR1 (0.62) HCRTR1HCRTR2CTSAKLKB1HTR1A
SCHEMBL2017304 0.77 HCRTR1 (0.43) HCRTR1HCRTR2CTSAKLKB1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed